Clinical Trial Update: A Study of Subjects Switched to Lurasidone for the Treatment of Schizophrenia or Schizoaffective Disorder [Phase 3]

View source ↗

Summary

Phase 3 study evaluating switching to lurasidone for schizophrenia or schizoaffective disorder; results were posted after completion in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizoaffective Disorder
• Schizophrenia

Drugs mentioned

• Lurasidone (Latuda) (lurasidone)

Snippet

Sponsor: Sumitomo Pharma America, Inc. | Conditions: Schizophrenia, Schizoaffective Disorder | Phase 3 | Status: COMPLETED | Results posted: 2012-12-17